# | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
---|---|---|---|---|---|---|---|---|---|
1. | ALA672139 | Functional | Concentration required to cause a microscopically detectable alteration of normal cell morphology in E6SM cells | Homo sapiens | 14 | ALA1125605 | cell-based format | Scientific Literature | |
2. | ALA672140 | Functional | Concentration required to inhibit HSV-1 (F) induced cytopathogenicity in E6SM cells by 50%. | Homo sapiens | 13 | ALA1125605 | cell-based format | Scientific Literature | |
3. | ALA671311 | Functional | Concentration required to inhibit HSV-1 (KOS) induced cytopathogenicity in E6SM cells by 50%. | Homo sapiens | 14 | ALA1125605 | cell-based format | Scientific Literature | |
4. | ALA671312 | Functional | Concentration required to inhibit HSV-1 (McIntyre) induced cytopathogenicity in E6SM cells by 50%. | Homo sapiens | 13 | ALA1125605 | cell-based format | Scientific Literature | |
5. | ALA671314 | Functional | Concentration required to inhibit HSV-2(196) induced cytopathogenicity in E6SM cells by 50%. | Homo sapiens | 14 | ALA1125605 | cell-based format | Scientific Literature | |
6. | ALA674354 | Functional | Concentration required to inhibit HSV-2(G) induced cytopathogenicity in E6SM cells by 50%. | Homo sapiens | 13 | ALA1125605 | cell-based format | Scientific Literature | |
7. | ALA674355 | Functional | Concentration required to inhibit HSV-2(lyons) induced cytopathogenicity in E6SM cells by 50%. | Homo sapiens | 14 | ALA1125605 | cell-based format | Scientific Literature | |
8. | ALA674356 | Functional | Concentration required to inhibit TK-HSV-1 (B2006) induced cytopathogenicity in E6SM cells by 50%. | Homo sapiens | 14 | ALA1125605 | cell-based format | Scientific Literature | |
9. | ALA674357 | Functional | Concentration required to inhibit TK-HSV-1 (VMW1837) induced cytopathogenicity in E6SM cells by 50%. | Homo sapiens | 13 | ALA1125605 | cell-based format | Scientific Literature | |
10. | ALA857932 | Functional | Concentration required to inhibit VSV induced cytopathogenicity in E6SM cells by 50%. | Homo sapiens | 14 | ALA1125605 | cell-based format | Scientific Literature | |
11. | ALA677330 | Functional | oncentration required to inhibit VV induced cytopathogenicity in E6SM cells by 50%. | Homo sapiens | 14 | ALA1125605 | cell-based format | Scientific Literature | |
12. | ALA687471 | Functional | Concentration required to cause 50% reduction in HEL cell growth. | Homo sapiens | 14 | ALA1125605 | cell-based format | Scientific Literature | |
13. | ALA857200 | Functional | Concentration required to inhibit CMV (AD-169) induced cytopathogenicity in HEL cells by 50%. | Homo sapiens | 14 | ALA1125605 | cell-based format | Scientific Literature | |
14. | ALA687474 | Functional | Concentration required to inhibit CMV (Davis) induced cytopathogenicity in HEL cells by 50%. | Homo sapiens | 11 | ALA1125605 | cell-based format | Scientific Literature | |
15. | ALA687477 | Functional | Concentration required to inhibit TK-VZV (07-1) induced cytopathogenicity in HEL cells by 50%. | Homo sapiens | 14 | ALA1125605 | cell-based format | Scientific Literature | |
16. | ALA687630 | Functional | Concentration required to inhibit TK-VZV (YSR) induced cytopathogenicity in HEL cells by 50%. | Homo sapiens | 14 | ALA1125605 | cell-based format | Scientific Literature | |
17. | ALA692682 | Functional | Concentration required to inhibit VZV (YS) induced cytopathogenicity in HEL cells by 50%. | Homo sapiens | 14 | ALA1125605 | cell-based format | Scientific Literature | |
18. | ALA692684 | Functional | Concentration required to inhibit VZV (oka) induced cytopathogenicity in HEL cells by 50%. | Homo sapiens | 14 | ALA1125605 | cell-based format | Scientific Literature |